Endoscopes Market Size, Share & Trends Analysis Report By Product (Rigid Endoscopes, Flexible Endoscopes, Disposable Endoscopes, Capsule Endoscopes), By End-use (Outpatient Facilities, Hospitals), By Region, And Segment Forecasts, 2025 - 2030

Endoscopes Market Size, Share & Trends Analysis Report By Product (Rigid Endoscopes, Flexible Endoscopes, Disposable Endoscopes, Capsule Endoscopes), By End-use (Outpatient Facilities, Hospitals), By Region, And Segment Forecasts, 2025 - 2030

Endoscopes Market Growth & Trends

The global endoscopes market size is estimated to reach USD 33.45 billion by 2030, registering a CAGR of 4.88% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing awareness levels about minimally invasive surgical procedures and the increasing prevalence of chronic disorders are the major factors accelerating the market growth. The benefits, such as less surgery-related blood loss, no muscle cutting, and quicker recovery, offered by minimally invasive surgeries boost the adoption of endoscopic procedures over traditional/open invasive surgeries. In addition, advancement in endoscopic technology and rapid increase of its application to diagnose and treat various diseases are other key factors anticipated to propel the market growth over the forecast years. The flexible endoscopes product segment expected to grow at a significant CAGR over the forecast period.

This is attributed to the high demand for these devices considering their unique features, such as the ability to reach viscera and cavities, better safety and efficiency, and improved ergonomic features. These devices are most commonly used in several endoscopic procedures, such as esophagogastroduodenoscopy (EGD), bronchoscopy, sigmoidoscopy, laryngoscopy, pharyngoscopy, nasopharyngoscopy, rhinoscopy, and colonoscopy procedures, which supports the product demand and segment growth.

In 2024, the outpatient facilities end-use segment dominated the market. Increasing adoption of endoscopes across outpatient facilities such as ambulatory surgery centers and diagnostic clinics for the early diagnosis and detection of several life-threatening diseases is supporting the segment growth. In addition, the introduction of keyhole endoscopic surgeries with minimal discomfort and faster recovery time also boosts the segment growth. In addition, North America held the largest revenue share in 2024 owing to its better healthcare infrastructure, high preference for minimally invasive surgical procedures among individuals, and quick adoption of advanced technologies. The increasing burden of functional gastrointestinal disorders and cancer is anticipated to further propel market growth in this region. For instance, as per the data reported by the National Cancer Institute, in 2020, over 1.8 million new cancer cases were estimated to be diagnosed in the U.S.

Several industry consolidation activities, such as mergers & acquisitions, and partnerships have resulted in a strong market share of the global market. Manufacturers in the market are also focusing on launching new endoscopes with advanced features as per patients’ requirements, to enhance their market share and consumer base. For instance, in January 2021, Karl Storz SE & Co. KG announced the launch of Image 1 S Rubina, which combines multimode fluorescence imaging with 4K resolution for endoscopy procedures. The toggling between white light and fluorescence modes allows surgeons to set it per surgical needs.

Endoscopes Market Report Highlights

• Based on product, the reusable endoscopes segment dominated the market with revenue share of 87.4% in 2024. The segment’s growth is driven by the rising occurrence of chronic diseases impacting internal body systems and the superior benefits of flexible endoscopes compared to other devices
• In terms of end-use, the outpatient facilities’ segment dominated the market in 2024 and accounted for the largest revenue share of 53.6% due to widespread adoption of keyhole or minimal invasive surgeries across these facilities
• North America dominated the market in 2024 owing to various factors including the increasing burden of functional gastrointestinal disorders, improved healthcare infrastructure, and the growing preference for minimally invasive surgeries to curb healthcare spending.

Please note The report will be delivered in 2-3 business days upon order notification.